83 related articles for article (PubMed ID: 12635724)
1. Incremental and average cost-effectiveness ratios: will physicians make a distinction?
Hershey JC; Asch DA; Jepson C; Baron J; Ubel PA
Risk Anal; 2003 Feb; 23(1):81-9. PubMed ID: 12635724
[TBL] [Abstract][Full Text] [Related]
2. The influence of cost-effectiveness information on physicians' cancer screening recommendations.
Ubel PA; Jepson C; Baron J; Hershey JC; Asch DA
Soc Sci Med; 2003 Apr; 56(8):1727-36. PubMed ID: 12639589
[TBL] [Abstract][Full Text] [Related]
3. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness of a cervical cancer screening programme in the Algarve region, Portugal].
Novoa Vázquez RM
Rev Esp Salud Publica; 2004; 78(3):341-53. PubMed ID: 15293955
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness studies on cervical cancer.
Brown AD; Raab SS; Suba EJ; Wright RG;
Acta Cytol; 2001; 45(4):509-14. PubMed ID: 11480710
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
8. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
[TBL] [Abstract][Full Text] [Related]
9. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia.
Ezat SW; Aljunid S
Asian Pac J Cancer Prev; 2010; 11(4):943-51. PubMed ID: 21133606
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of cervical cancer screening: comparison of screening policies.
van den Akker-van Marle ME; van Ballegooijen M; van Oortmarssen GJ; Boer R; Habbema JD
J Natl Cancer Inst; 2002 Feb; 94(3):193-204. PubMed ID: 11830609
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
[TBL] [Abstract][Full Text] [Related]
13. [Costs and problems in cervix cancer screening are considerably underestimated].
Bistoletti P
Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
15. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
Goldie SJ; Kohli M; Grima D; Weinstein MC; Wright TC; Bosch FX; Franco E
J Natl Cancer Inst; 2004 Apr; 96(8):604-15. PubMed ID: 15100338
[TBL] [Abstract][Full Text] [Related]
16. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
17. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
Perovic S
J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
[TBL] [Abstract][Full Text] [Related]
19. Cost-effective policies for cervical cancer screening. An international review.
Fahs MC; Plichta SB; Mandelblatt JS
Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
[TBL] [Abstract][Full Text] [Related]
20. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
